ATE207118T1 - Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer - Google Patents

Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer

Info

Publication number
ATE207118T1
ATE207118T1 AT94912292T AT94912292T ATE207118T1 AT E207118 T1 ATE207118 T1 AT E207118T1 AT 94912292 T AT94912292 T AT 94912292T AT 94912292 T AT94912292 T AT 94912292T AT E207118 T1 ATE207118 T1 AT E207118T1
Authority
AT
Austria
Prior art keywords
yeast cells
pheroma
applications
surrogate
produce protein
Prior art date
Application number
AT94912292T
Other languages
English (en)
Inventor
Dana Merriman Fowlkes
Jim Broach
John Manfredi
Christine Klein
Andrew J Murphy
Jeremy Paul
Joshua Trueheart
Original Assignee
Cadus Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadus Pharmaceutical Corp filed Critical Cadus Pharmaceutical Corp
Application granted granted Critical
Publication of ATE207118T1 publication Critical patent/ATE207118T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cash Registers Or Receiving Machines (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94912292T 1993-03-31 1994-03-23 Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer ATE207118T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4143193A 1993-03-31 1993-03-31
US19032894A 1994-01-31 1994-01-31
PCT/US1994/003143 WO1994023025A1 (en) 1993-03-31 1994-03-23 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor

Publications (1)

Publication Number Publication Date
ATE207118T1 true ATE207118T1 (de) 2001-11-15

Family

ID=26718132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912292T ATE207118T1 (de) 1993-03-31 1994-03-23 Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer

Country Status (10)

Country Link
EP (2) EP0692025B1 (de)
JP (3) JPH08510115A (de)
AT (1) ATE207118T1 (de)
AU (2) AU685103B2 (de)
CA (1) CA2158274C (de)
DE (1) DE69428689T2 (de)
DK (1) DK0692025T3 (de)
ES (1) ES2166371T3 (de)
PT (1) PT692025E (de)
WO (1) WO1994023025A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789184A (en) * 1993-03-31 1998-08-04 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6864060B1 (en) 1993-03-31 2005-03-08 Cadus Technologies, Inc. Yeast cells expressing modified G proteins and methods of use therefor
US6255059B1 (en) 1993-03-31 2001-07-03 Cadus Pharmaceutical Corporation Methods for identifying G protein coupled receptor effectors
US7235648B1 (en) 1993-03-31 2007-06-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US7416881B1 (en) 1993-03-31 2008-08-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US20030054402A1 (en) 1993-03-31 2003-03-20 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US6100042A (en) 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5876951A (en) * 1993-03-31 1999-03-02 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US6001553A (en) * 1994-04-26 1999-12-14 Cadus Pharmaceutical Corporation Functional expression of mammalian adenylyl cyclase in yeast
WO1996034112A1 (en) * 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
JP2001507201A (ja) * 1995-06-07 2001-06-05 カダス・フアーマシユーチカル・コーポレーシヨン 酵母での機能的脊椎動物ホスホリパーゼの発現
CA2232733A1 (en) * 1995-09-20 1997-03-27 Orikkalapat Prem Das Yeast receptor and g-protein fusion protein
AU3055697A (en) * 1996-04-23 1997-11-12 Cadus Pharmaceutical Corporation Functional expression of heterologous adenylyl cyclase
US5783431A (en) * 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US6242211B1 (en) 1996-04-24 2001-06-05 Terragen Discovery, Inc. Methods for generating and screening novel metabolic pathways
ATE224454T1 (de) * 1996-04-26 2002-10-15 Massachusetts Inst Technology Drei hybriden screening test
JP2001501097A (ja) * 1996-09-24 2001-01-30 ケイダス ファーマスーティカル コーポレイション レセプターエフェクターを同定する方法及び組成物
JP2002504827A (ja) 1997-06-11 2002-02-12 ニューヨーク ユニバーシティ プレニルシステインカルボキシルメチルトランスフェラーゼ、これをコード化するｄｎａ、およびその阻害剤のためのスクリーニング方法
AU9791198A (en) * 1997-10-07 1999-04-27 Cadus Pharmaceutical Corporation Yeast cells expressing modified g proteins and methods of use therefor
US6355473B1 (en) 1998-05-06 2002-03-12 Cadus Pharmaceutical Corp. Yeast cells having mutations in stp22 and uses therefor
WO1999058670A1 (en) * 1998-05-08 1999-11-18 Cadus Pharmaceutical Corporation Ags proteins and nucleic acid molecules and uses therefor
US6733991B1 (en) 1998-05-08 2004-05-11 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses therefor
US6746852B1 (en) 1998-05-08 2004-06-08 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses thereof
US20020015967A1 (en) * 1998-06-02 2002-02-07 Lauren Silverman Functional expression of adenosine receptors in yeast
US7081360B2 (en) 1998-07-28 2006-07-25 Cadus Technologies, Inc. Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
US7273747B2 (en) 1998-08-27 2007-09-25 Cadus Technologies, Inc. Cell having amplified signal transduction pathway responses and uses therefor
US6251605B1 (en) 1998-10-27 2001-06-26 Cadus Pharmaceutical Corporation Yeast cells having mutations in Cav1 and uses therefor
WO2000031261A2 (en) 1998-11-25 2000-06-02 Cadus Pharmaceutical Corporation Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
US6504008B1 (en) 1999-02-01 2003-01-07 Cadus Technologies, Inc. Cell based signal generation
US6555325B1 (en) 1999-06-14 2003-04-29 Cadus Technologies, Inc. System for detection of a functional interaction between a compound and a cellular signal transduction component
US7223533B2 (en) 1999-09-10 2007-05-29 Cadus Technologies, Inc. Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
GB0030038D0 (en) * 2000-12-08 2001-01-24 Univ Warwick Yeast-based assay
ES2360205T3 (es) 2001-03-02 2011-06-01 Agennix Ag Sistema de ensayo de tres híbridos.
NZ513755A (en) 2001-08-24 2001-09-28 Ann Rachel Holmes Protein expression system in yeast comprising a vector encoding a heterologous membrane protein and its application in screening for drugs
CA2861104A1 (en) * 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd. Rifaximin derivative and uses thereof
CA3108922A1 (en) * 2018-08-29 2020-03-05 Amyris, Inc. Cells and methods for selection based assay
CN109593773B (zh) * 2018-11-22 2021-07-30 北京利德曼生化股份有限公司 一种应用酵母表达***表达可溶性生长刺激表达基因2蛋白的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010308A1 (en) * 1987-06-24 1988-12-29 Whitehead Institute For Biomedical Research Pheromone-inducible yeast promoter
US5284746A (en) * 1990-02-08 1994-02-08 Zymogenetics, Inc. Methods of producing hybrid G protein-coupled receptors
CA2092717C (en) * 1990-09-13 2001-06-12 Klim King Expression of g protein coupled receptors in yeast

Also Published As

Publication number Publication date
CA2158274C (en) 2000-05-30
EP0692025B1 (de) 2001-10-17
ES2166371T3 (es) 2002-04-16
DK0692025T3 (da) 2002-02-11
AU6354198A (en) 1998-07-09
CA2158274A1 (en) 1994-10-13
JP2004357713A (ja) 2004-12-24
JPH08510115A (ja) 1996-10-29
AU6490994A (en) 1994-10-24
AU685103B2 (en) 1998-01-15
EP0915154A1 (de) 1999-05-12
JP2004337174A (ja) 2004-12-02
EP0692025A1 (de) 1996-01-17
DE69428689D1 (de) 2001-11-22
DE69428689T2 (de) 2002-08-08
PT692025E (pt) 2002-04-29
WO1994023025A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
ATE207118T1 (de) Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer
ATE175666T1 (de) N-(benzofurazanyl)-arylsulfonamide und ihre analoge verwendbar als endothelin-rezeptor- antagonisten
ATE259060T1 (de) Codierung und decodierung von sensor-arrays mittels nanokristalle
DE69434299T2 (de) Thiol-derivatisierte Nukleoside und Oligonukleoside
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
DE60203125D1 (de) Löslicher t zell rezeptor
DE69936312D1 (de) Mutanten von op-1
ATE186551T1 (de) Medikamente bindendes protein
AU7266896A (en) A novel haemopoietin receptor and genetic sequences encoding same
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
NZ500577A (en) Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins
ATE286073T1 (de) Antikörper gegen spaltprodukte von vimentin
WO2004042567A3 (en) Information processing systems configured and manipulated under an application framework
WO1997047732A3 (en) Hexameric fusion proteins and uses therefor
WO2003032898A3 (en) Modified human thymic stromal lymphopoietin
DE59801230D1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
PT882229E (pt) Sistema de ensaio elisa
DE69315989D1 (de) Aminoterminale prokollagen 1(i) peptide
ATE447027T1 (de) Bakterielle pheromone und deren verwendungen
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
WO1996023883A3 (en) Modified ligands for receptor tyrosine kinases
BR9814866A (pt) Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica
GB0103024D0 (en) Assay for Autoantibodies to tissue transglutaminase
ATE229663T1 (de) Feuerwehr-leitstellensystem mit zumindest einem bildschirmsichtgerät
Bennett The use of risk-based assessment techniques to optimise inspection regimes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee